WAY-270360

CAS No. 476633-98-4

WAY-270360( N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide )

Catalog No. M28522 CAS No. 476633-98-4

WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 188 In Stock
25MG 332 In Stock
50MG 456 In Stock
100MG 642 In Stock
200MG Get Quote In Stock
500MG 1274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-270360
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    476633-98-4
  • Formula Weight
    373.412
  • Molecular Formula
    C22H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(C(=O)Nc2ccc(cc2)-c2nc3ccccc3[nH]2)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD8931 diFuMaric ac...

    AZD8931 is a reversible and ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 (IC50 of 4 nM, 3 nM and 4 nM, respectively).AZD8931 significantly suppressed cell growth of IBC cells and induced apoptosis of human IBC cells in vitro.AZD8931 monotherapy inhibited xenograft growth.

  • HKI-357

    HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 (IC50s: 34 nM and 33 nM). HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation.

  • CO-1686 hydrobromide

    A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.